US pharmaceutical company Eli Lilly and Company (NYSE:LLY) announced on Monday that its board of directors has approved a dividend of USD1.73 per share on its outstanding common stock for the second quarter of 2026.
This amount is unchanged from the previous quarterly dividend.
The Q2 dividend is payable on 10 June 2026, to shareholders of record at the close of business on 15 May 2026.
MedPal AI acquires eMARx to expand digital care home platform
Valerio Therapeutics signs R&D collaboration with Abivax and outlines pipeline milestones
Labcorp declares quarterly dividend of USD0.72 per share
Aptamer Group launches Optimer-based Ebola diagnostic programme
Nona Biosciences and Lonza collaborate on antibody-based BBB-crossing technology for CNS diseases
Lilly declares Q3 2026 dividend
Abbott declares quarterly dividend of USD0.63 per share
Gilead Sciences mobilises remdesivir donation to support Ebola response in Uganda
INOVIO's oartner ApolloBio reports positive topline results from Phase 3 trial of VGX-3100